The association of aneurysms related to arteriovenous fistulas and chronic hepatitis C virus infection in maintenance hemodialysis

Amaç: Bu çalışmada idame hemodiyaliz (HD) tedavisi gören hastalarda arteriyovenöz fistüllerin (AVF) anevrizmaları ile hepatit C virus (HCV) enfeksiyonunun muhtemel birlikteliği araştırıldı.Çalışma planı: Bu kesitsel çalışmada, Ocak 2010 - Aralık 2010 tarihleri arasında Van Yüzüncü Yıl Üniversite hastanesine yönlendirilen AVF'li 179 HD hastası değerlendirildi. Yaş, cinsiyet, renal yetmezlik süresi, ameliyat edilen fistül sayısı, anevrizmal fistülü olan hasta sayısı ve kronik HCV enfeksiyonu verileri kaydedildi. Arteriyovenöz fistül açıklığı ve anevrizmal akımı belirlemek için Dopler ultrasonografi yapıldı.Bul gu lar: Otuz üç hastada (grup A) anevrizma vardı ve anevrizması olan 33 hastanın 21'inde (grup A1) kronik HCV enfeksiyonu varken, 12 hastada (grup A2) kronik HCV enfeksiyonu yoktu. Yüz kırk altı hastada (grup B) anevrizma yoktu. Bu hastaların 15'inde (grup B1) kronik HCV enfeksiyonu vardı, 131'inde (grup B2) kronik HCV enfeksiyonu yoktu. Gruplar arasında yaş, cinsiyet, renal yetmezlik açısından istatistiksel fark yoktu. Ortalama AVF akımı grup A1'de (856±123 ml/dk.) group A2'ye (560±98 ml/dk.) göre daha yüksek idi (p

İdame hemodiyaliz tedavisi gören hastalarda arteriyovenöz fistül anevrizmaları ile kronik hepatit C virüs enfeksiyonunun birlikteliği

Background: This study aims to investigate a possible association of aneurysm of arteriovenous fistulas (AVFs) and chronic hepatitis C virus (HCV) infection in maintenance hemodialysis (HD) patients. Methods: In this cross-sectional study, 179 HD patients with AVFs who were referred to Van Yüzüncü Yıl University Hospital between January 2010 and December 2010 were evaluated. Data including age, sex, duration of renal failure, number of operated fistulas, number of patients with aneurysmal fistulas and chronic HCV infection were recorded. Doppler ultrasonography was performed to determine AVF patency and aneurysm flow. Results: Thirthy-three patients (group A) had aneurysm and 21 (group A1) of these patients had chronic HCV infection, while 12 (group A2) had no chronic HCV infection. Hundred and forty-six patients (group B) had no aneurysm. Of these patients, 15 (group B1) had chronic HCV infection, while 131 (group B2) had no chronic HCV infection. There were no statistical differences in age, sex, and duration of renal failure between the groups. The mean AVF flow was higher in group A1 (856±123 ml/min) compared to group A2 (560±98 ml/min) (p

PDF

___

1. Braunwald E, Fauci A, Ajay KS, Barry M. Harrsison’s principles of internal medicine. 15th ed. Philadelphia: McGraw-Hill; 2005.
2. Kanterman RY, Vesely TM, Pilgram TK, Guy BW, Windus DW, Picus D. Dialysis access grafts: anatomic location of venous stenosis and results of angioplasty. Radiology 1995;195:135-9.
3. Patel KR, Chan FA, Batista RJ, Clauss RH. True venous aneurysms and arterial “steal” secondary to arteriovenous fistulae for dialysis. J Cardiovasc Surg (Torino) 1992;33:185-8.
4. Hauser H, Gutschi S, Fruhwirth H, Koch G. Dialyseshuntaneurysmen: Pathologische und therapeutische Aspekte. Nieren- und Hochdruckkrankheiten 1996;25:1-3.
5. Schanzer H, Skladany M. Vascular access for dialysis. In: Haimovici H, editor. Vascular surgery. 4th ed. Cambridge: Blackwell Sciences; 1996. p. 1028-41.
6. Wahl W, Bredel J, Wandel E, Schnütgen M, Mann M, Junginger T. Surgical management of dysfunctions of dialysis fistulas. Langenbecks Arch Chir 1997;382:237-42. [Abstract]
7. Derakhshanfar A, Gholyaf M, Niayesh A, Bahiraii S. Assessment of frequency of complications of arterio venous fistula in patients on dialysis: a two-year single center study from Iran. Saudi J Kidney Dis Transpl 2009;20:872-5.
8. Akyüz F, Beşişik F, Pinarbaşi B, Demir K, Kaymakoğlu ST, Cakaloğlu Y, et al. The quality of life in hemodialysis patients with chronic hepatitis C virus infection. Turk J Gastroenterol 2009;20:243-6.
9. Martin P, Fabrizi F. Hepatitis C virus and kidney disease. J Hepatol 2008;49:613-24.
10. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, LoustaudRatti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore) 2000;79:47-56.
11. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117:573-7.
12. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775-88.
13. Cacoub P, Maisonobe T, Thibault V, Gatel A, Servan J, Musset L, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 2001;28:109-18.
14. Dammacco F, Sansonno D, Piccoli C, Tucci FA, Racanelli V. The cryoglobulins: an overview. Eur J Clin Invest 2001;31:628-38.
15. Charles ED, Dustin LB. Hepatitis C virus-induced cryoglobulinemia. Kidney Int 2009;76:818-24.
16. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966;40:837-56.
17. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
18. Gorevic, PD. Cryopathies: Cryoglobulins and cryofibrinogenimia. In: Frank MM, Austen, KF, Claman, HN, editors. Samter’s Immunologic diseases. Vol. 5. Vol. 2. Boston: Little, Brown and Company; 1995. p. 951-6.
19. Bichard P, Ounanian A, Girard M, Baccard C, Rolachon A, Renversez JC, et al. High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia. J Hepatol 1994;21:58-63.
20. Zibari GB, Rohr MS, Landreneau MD, Bridges RM, DeVault GA, Petty FH, et al. Complications from permanent hemodialysis vascular access. Surgery 1988;104:681-6.
21. Kade G, Zagrodzka M, Prokopiuk M, Wierzbicki P, Dziekiewicz M, Wankowicz Z. Pseudoaneurysm of arteriovenous fistula for haemodialysis. Pol Merkur Lekarski 2002;13:399-402. [Abstract]
22. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003;42:631-57.
23. World Health Organization. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 1999;74:425-7.
24. Zignego AL, Craxì A. Extrahepatic manifestations of hepatitis C virus infection. Clin Liver Dis 2008;12:611-36.
25. Zignego AL, Giannini C, Monti M, Gragnani L. Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 2007;39 Suppl 1:S38-45.
26. Zignego AL, Ferri C, Giannini C, La Civita L, Careccia G, Longombardo G, et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997;142:545-55.
27. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993;82:3701-4.
28. Shichi D, Matsumori A, Naruse TK, Inoko H, Kimura A. HLA-DPbeta chain may confer the susceptibility to hepatitis C virus-associated hypertrophic cardiomyopathy. Int J Immunogenet 2008;35:37-43.
29. Ishizaka N, Ishizaka Y, Takahashi E, Tooda Ei, Hashimoto H, Nagai R, et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002;359:133-5.
30. Ishizaka N, Ishizaka Y, Takahashi E, Toda Ei E, Hashimoto H, Ohno M, et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 2002;105:1028-30.
31. Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, et al. Serum levels of gamma-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection. Hepatol Res 2003;25:14-21.
32. Kırış S, Direşkendi H, Özener Ç, Akoğlu E. Cryoglobulinemia prevalance and relation with HCV infection in chronic hemodialysis patients. J of Turkish Nephrology 1996;3:110-4.
33. Janicki K, Pietura R, Radzikowska E, Załuska W, Bicki J. The obtention of vascular access on the arm for hemodialysis. Ann Univ Mariae Curie Sklodowska Med 2001;56:206-11.
34. Eugster T, Wigger P, Bölter S, Bock A, Hodel K, Stierli P. Brachial artery dilatation after arteriovenous fistulae in patients after renal transplantation: a 10-year follow-up with ultrasound scan. J Vasc Surg 2003;37:564-7.
35. Gharbi MB, Hachim K, Ramdani B, Jabrane AJ, Fatihi E, Zahiri K, et al. Arteriovenous fistula. Apropos of a local experience in Morocco. Nephrologie 1998;19:33-6. [Abstract]
36. Nguyen DQ, Ruddle AC, Thompson JF. Late axillobrachial arterial aneurysm following ligated BresciaCimino haemodialysis fistula. Eur J Vasc Endovasc Surg 2001;22:381-2.
37. Gross CW, Kobinia GS, Brücke P. Progressive arterial aneurysm formation proximal to a ligated peripheral arteriovenous fistula. Vasa 1986;15:256-8.